Compare Stocks

Back to Screener

Popular Stock Comparisons

Explore popular stock comparison combinations in the Indian stock market to analyze stock performance, share price, and company financial position for better investment decisions.

Select Stocks to Compare

Add or remove up to 5 stocks to perform stock analysis, comparing market price, stock performance, and financial statements for informed decisions.

Stock Comparison Charts

Metric
Sun Pharmaceutical Industries Limited

Healthcare

Drug Manufacturers - Specialty & Generic
Dr. Reddy's Laboratories Limited

Healthcare

Drug Manufacturers - Specialty & Generic
Cipla Limited

Healthcare

Drug Manufacturers - Specialty & Generic
Aurobindo Pharma Limited

Healthcare

Drug Manufacturers - Specialty & Generic
Stock Details
Current Price 1681.7 1254.3 1479.8 1133.2
Previous Close 1672.0 1254.7 1485.0 1124.8
Open 1680.4 1254.7 1488.9 1124.7
Day Low 1675.5 1248.0 1476.0 1122.6
Day High 1690.3 1258.0 1488.9 1136.7
Market Cap 4054023667712.0 1089783595008.0 1216117342208.0 693448081408.0
P/E Ratio 36.84 18.51 22.7 18.94
Forward P/E 51.46 3.66 23.29 18.19
Earnings Per Share 45.65 67.75 65.19 59.84
Dividend Yield (%) 0.66 0.62 0.86 0.4
Beta 0.38 0.39 0.16 0.22
EBITDA 150861594624.0 88840003584.0 70221398016.0 66054397952.0
Book Value 302.32 400.7 386.24 562.37
Debt to Equity 3.26 13.87 1.4 25.31
ROCE (%) N/A N/A N/A N/A
ROE (%) N/A N/A N/A N/A
Face Value N/A N/A N/A N/A
Price to Book 5.56 3.13 3.83 2.02
Performance
1Y Return (%) 540.92 -767.14 -212.23 -1818.74
About Company
Founded Year N/A N/A N/A N/A
Employees N/A 27811 30313 N/A
Website Live Website of SUNPHARMA Live Website of DRREDDY Live Website of CIPLA Live Website of AUROPHARMA

Company Overviews & Financial Position

Review detailed company profiles, including business summaries and key insights into their balance sheet and company financial position to aid in buying or selling decisions.

Sun Pharmaceutical Industries Limited

Sun Pharmaceutical Industries Limited, a generic pharmaceutical company, develops, manufactures, and markets branded and generic formulations and active pharmaceutical ingredients (APIs) in India and internationally. The company offers formulations in various therapeutic areas, including central nervous system, dermatology, cardiology, oncology, neuropsychiatry, gastroenterology, anti-infectives, diabetology, pain/analgesics, vitamins/minerals/nutrients, respiratory, gynaecology, urology, ophthalmology, orthopaedic, nephrology, dental, and other areas. It provides APIs for anti-cancers, peptides, steroids, hormones, and immunosuppressant drugs. In addition, the company offers generic medications, such as tablets, capsules, injectables, inhalers, ointments, creams, and liquids; speciality medications, and antiretrovirals medications, as well as over-the-counter products. The company was founded in 1983 and is headquartered in Mumbai, India.

Dr. Reddy's Laboratories Limited

Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company North America, Europe, India, Russia, and internationally. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), and Others segment. The Global Generics segment manufactures and markets prescription and over-the-counter finished pharmaceutical products that are marketed under a brand name or as a generic finished dosages with therapeutic equivalence to branded formulations, as well as engages in the biologics business. The PSAI segment manufactures and markets active pharmaceutical ingredients and intermediates, which are principal ingredients for finished pharmaceutical products. This segment also provides contract research services; and manufactures and sells active pharmaceutical ingredients and steroids with the customer requirements. The Others segment engages in developing therapies in the fields of oncology and inflammation; and research and development of differentiated formulations. The company offers its products for various therapeutic categories, including gastro-intestinal, cardiovascular, anti-diabetic, dermatology, oncology, respiratory, stomatology, urology, and nephrology, vaccines and pain management. Dr. Reddy's Laboratories Limited was incorporated in 1984 and is headquartered in Hyderabad, India.

Cipla Limited

Cipla Limited, together with its subsidiaries, manufactures, develops, sells, and distributes pharmaceutical products in India, the United States, South Africa, and internationally. The company operates through Pharmaceuticals and New Ventures segments. It offers generic and branded generic medicines, vaccines, active pharmaceutical ingredients, and formulations for various therapeutic areas, such as MI, angina, heart disease, pulmonary disease, kidney failure, Alzheimer's disease, hypertension, arrhythmia, lipid abnormalities and diabetes, obesity, central nervous system, HIV/AIDS, respiratory, asthma, urology, oncology, cardio-metabolism, child health, infectious diseases and critical care, hepatitis, women's health, ophthalmology, and neuro psychiatry. The company is also involved in the consumer healthcare, biosimilars, and specialty businesses. Cipla Limited was incorporated in 1935 and is based in Mumbai, India.

Aurobindo Pharma Limited

Aurobindo Pharma Limited, a biopharmaceutical company, engages in the manufacture of generic formulations and active pharmaceutical ingredients in India, the United States of America, Europe, Puerto Rico, and internationally. The company offers formulation in form of oral solids, liquids, injectables, and vaccines, as well as over-the-counter drugs; and active pharmaceutical ingredients (APIs), biosimilars, biocatalysts, peptides, and hormones targeting key therapeutic areas, including central nervous system, cardiovascular, respiratory, antibiotics, anti-retroviral, anti-diabetics, gastroenterology, oncology, and dermatology. It also provides antiretroviral drugs for the people and children living with HIV; and provides project-based chemistry contract services that cover the clinical stage through to manufacturing and management of the entire drug lifecycle in the API space for sterile and non-sterile penicillin's, cephalosporins, penems, and non-beta lactams. The company was incorporated in 1986 and is headquartered in Hyderabad, India.

You May Be Interested In